Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 1
2015 2
2016 2
2017 4
2018 1
2019 1
2021 4
2022 3
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Th17 Response in COVID-19.
Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. Martonik D, et al. Among authors: parfieniuk kowerda a. Cells. 2021 Jun 19;10(6):1550. doi: 10.3390/cells10061550. Cells. 2021. PMID: 34205262 Free PMC article. Review.
Emerging treatments for hepatitis C.
Flisiak R, Jaroszewicz J, Parfieniuk-Kowerda A. Flisiak R, et al. Among authors: parfieniuk kowerda a. Expert Opin Emerg Drugs. 2013 Dec;18(4):461-75. doi: 10.1517/14728214.2013.847089. Epub 2013 Oct 8. Expert Opin Emerg Drugs. 2013. PMID: 24102413 Review.
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R; WES/WGS Working Group Within the HGI; GenOMICC Consortium; GEN-COVID Multicenter Study; Mari F, Renieri A, Furini S. Fallerini C, et al. Hum Genet. 2022 Jan;141(1):147-173. doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. Hum Genet. 2022. PMID: 34889978 Free PMC article.
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.
Tronina O, Brzdęk M, Zarębska-Michaluk D, Dybowska D, Lorenc B, Janczewska E, Mazur W, Parfieniuk-Kowerda A, Piekarska A, Krygier R, Klapaczyński J, Berak H, Jaroszewicz J, Garlicki A, Tomasiewicz K, Citko J, Flisiak R. Tronina O, et al. Among authors: parfieniuk kowerda a. Viruses. 2023 Mar 4;15(3):677. doi: 10.3390/v15030677. Viruses. 2023. PMID: 36992388 Free PMC article.
Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals.
Flisiak R, Zarębska-Michaluk D, Berak H, Dybowska D, Sitko M, Parfieniuk-Kowerda A, Janocha-Litwin J, Janczewska E, Piekarska A, Lorenc B, Mazur W, Dobrowolska K, Tudrujek-Zdunek M, Klapaczyński J, Jaroszewicz J. Flisiak R, et al. Among authors: parfieniuk kowerda a. Clin Exp Hepatol. 2023 Sep;9(3):193-201. doi: 10.5114/ceh.2023.130935. Epub 2023 Sep 3. Clin Exp Hepatol. 2023. PMID: 37790681 Free PMC article.
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Zarębska-Michaluk D, Flisiak R, Janczewska E, Berak H, Mazur W, Janocha-Litwin J, Krygier R, Dobracka B, Jaroszewicz J, Parfieniuk-Kowerda A, Dobrowolska K, Rzymski P. Zarębska-Michaluk D, et al. Among authors: parfieniuk kowerda a. Antiviral Res. 2023 Dec;220:105742. doi: 10.1016/j.antiviral.2023.105742. Epub 2023 Nov 7. Antiviral Res. 2023. PMID: 37944825 Free article.
33 results